Quick Summary

Putin and Xi were overheard speculating about living to 150—or even immortality, through organ transplants and biotechnology. Scientists say the idea of replacing organs to cheat death is unrealistic. But research in epigenetics, rapamycin, and cellular reprogramming is opening new doors to extend healthy lifespan. For now, the consensus is clear: living well matters more than living forever.

A conversation that sparked global curiosity

At a Beijing summit this week, Vladimir Putin and Xi Jinping were overheard musing about something more ambitious than politics: whether humans might live to 150—or even achieve immortality.

According to the hot-mic exchange, Putin suggested that with advances in biotechnology and organ transplants, people could theoretically “get younger as they grow older.” Xi responded by noting predictions that humans could reach 150 years of age within this century.

The comments, equal parts provocative and speculative, highlight how world leaders are paying attention to scientific debates around longevity. But how realistic are these visions?

Is there a limit to human lifespan?

Scientists remain divided on whether humans have a hard biological cap on longevity.

• The oldest confirmed age belongs to Jeanne Calment of France, who lived to 122 and died in 1997. That record has stood for nearly three decades.
• Some research suggests that mortality rates plateau at extreme ages, meaning that after 105, the chance of dying doesn’t dramatically increase. This raises the possibility that more people could reach 120 or beyond.
• Others argue the apparent plateau may be statistical noise—or even fraud, given cases of falsified birth records.

“The debate is not settled,” said Ilaria Bellantuono, an ageing researcher at the University of Sheffield. While health care advances have improved quality of life, they have not yet pushed life expectancy records further.

The organ replacement theory

Putin’s suggestion that regular organ transplants could make humans younger drew sharp criticism.

zEric Boulanger, a biology of ageing professor at Lille University, dismissed the idea as “pure madness.” He pointed out that:

• Organs cannot simply be swapped out like car parts.
• Ageing affects bones, connective tissue, and cells across the body—not just major organs.
• Repeated surgeries would impose immense physical trauma.
• The constant need for donor organs raises profound ethical and logistical issues.

In short, while regenerative medicine may offer targeted therapies, the vision of endlessly replacing body parts to achieve immortality is not scientifically credible.

The booming business of longevity

Despite skepticism, longevity has become a billion-dollar frontier:

• Russia launched a 38-billion-ruble ($460 million) project on regenerative medicine in 2024.
• Silicon Valley has turned “anti-ageing” into a lifestyle industry, with investors like Peter Thiel backing experimental projects.
• Tech entrepreneur Bryan Johnson has become a poster child for radical longevity efforts, testing extreme diets, therapies, and even plasma transfusions on himself.

Critics say much of this borders on pseudoscience, warning that hype risks overshadowing legitimate research.

Where real science is headed

The most promising advances are less about eternal youth and more about extending healthy years of life.

• Epigenetics: Scientists are investigating how the switching on/off of genes—without altering DNA itself—plays a key role in ageing.
• Rapamycin: This drug has extended lifespan in mice and other animals by slowing epigenetic ageing, though human results remain unproven.
• Cellular reprogramming: Early studies show potential for “resetting” cells to a younger state, but the technology is still experimental.

The common thread: these approaches target the biological mechanisms of ageing itself, not just symptoms.

Why it matters

Putin and Xi’s offhand exchange may sound far-fetched, but it reflects a very real global trend: the politics of ageing. Both leaders are 72, and neither has signaled plans to step aside. Their fascination with longevity mirrors the anxieties of aging populations worldwide, particularly in China and Russia.

Still, scientists caution against chasing immortality myths. “The focus should be on extending the number of years in good health,” Bellantuono emphasized. Quality of life, not infinite life, remains the practical goal of aging research.